SWTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.61%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $886,979.58

SpringWorks Therapeutics Insider Trading History Chart

SpringWorks Therapeutics Share Price & Price History

^$40.10

▼ -2.37 (-5.58%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

SpringWorks Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2024	Daniel Pichl	Insider	Sell	15,000	$50.10	$751,500.00	45,212
7/19/2023	Julie Hambleton	Director	Sell	2,418	$29.31	$70,871.58	4,648
6/20/2023	Julie Hambleton	Director	Sell	2,400	$26.92	$64,608.00	7,066
3/15/2023	Julie Hambleton	Director	Sell	1,106	$31.50	$34,839.00	4,818
1/26/2023	Daniel Pichl	Insider	Sell	858	$31.00	$26,598.00	35,203
9/12/2022	Orbimed Advisors Llc	Major Shareholder	Sell	153,897	$31.96	$4,918,548.12	5,599,842
10/20/2021	Saqib Islam	CEO	Sell	10,083	$58.67	$591,569.61
10/18/2021	Saqib Islam	CEO	Sell	38,340	$58.59	$2,246,340.60
10/13/2021	L. Mary Smith	Insider	Sell	10,000	$55.97	$559,700.00
8/10/2021	Bain Capital Life Sciences Inv	Major Shareholder	Sell	1,000,000	$70.25	$70,250,000.00
7/19/2021	Saqib Islam	CEO	Sell	43,928	$76.09	$3,342,481.52
7/13/2021	L. Mary Smith	Insider	Sell	10,000	$80.88	$808,800.00	177,511
7/1/2021	Badreddin Edris	COO	Sell	32,000	$85.35	$2,731,200.00
6/28/2021	Orbimed Advisors Llc	Major Shareholder	Sell	6,502	$85.17	$553,775.34
6/25/2021	Orbimed Advisors Llc	Major Shareholder	Sell	22,334	$85.14	$1,901,516.76
6/23/2021	Orbimed Advisors Llc	Major Shareholder	Sell	100	$85.00	$8,500.00
6/9/2021	Orbimed Advisors Llc	Major Shareholder	Sell	5,049	$85.33	$430,831.17
6/7/2021	Orbimed Advisors Llc	Major Shareholder	Sell	371	$84.90	$31,497.90
4/27/2021	Stephen P. Squinto	Director	Sell	201	$75.05	$15,085.05
4/19/2021	Saqib Islam	CEO	Sell	38,425	$69.04	$2,652,862.00	908,127

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

SEC Filings (Institutional Ownership Changes) for SpringWorks Therapeutics (NASDAQ:SWTX)

Institutional Buying and Selling by Quarter

SpringWorks Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Financial Security Advisor Inc.	5,000	$0.25M	0.1%	N/A	0.007%
4/17/2024	Hennion & Walsh Asset Management Inc.	37,512	$1.85M	0.1%	+14.4%	0.051%
4/5/2024	Los Angeles Capital Management LLC	14,511	$0.71M	0.0%	N/A	0.020%
3/27/2024	Nomura Holdings Inc.	12,690	$0.46M	0.0%	N/A	0.017%
3/11/2024	Vanguard Group Inc.	6,036,542	$220.33M	0.0%	+22.6%	8.181%
3/5/2024	Wellington Management Group LLP	21,167	$0.77M	0.0%	N/A	0.029%
3/1/2024	Goldman Sachs Group Inc.	461,275	$16.84M	0.0%	-22.1%	0.625%
2/28/2024	American International Group Inc.	33,357	$1.22M	0.0%	+14.7%	0.053%
2/26/2024	Perceptive Advisors LLC	1,957,246	$71.44M	1.6%	+28.7%	3.128%
2/22/2024	Sierra Summit Advisors LLC	7,022	$0.26M	0.1%	N/A	0.011%
2/20/2024	Quarry LP	3,750	$0.14M	0.0%	-17.0%	0.006%
2/16/2024	Price T Rowe Associates Inc. MD	2,776,570	$101.35M	0.0%	+78.5%	4.437%
2/15/2024	Virtus ETF Advisers LLC	9,406	$0.34M	0.2%	+162.0%	0.015%
2/15/2024	Legal & General Group Plc	49,669	$1.81M	0.0%	+32.0%	0.079%
2/15/2024	Barclays PLC	154,273	$5.63M	0.0%	+57.6%	0.247%
2/15/2024	Sphera Funds Management LTD.	170,270	$6.22M	1.0%	-46.8%	0.272%
2/15/2024	Vanguard Group Inc.	6,036,542	$220.33M	0.0%	+22.6%	9.646%
2/15/2024	Voloridge Investment Management LLC	500,749	$18.28M	0.1%	+572.1%	0.800%
2/15/2024	Voya Investment Management LLC	45,520	$1.66M	0.0%	+8.5%	0.073%
2/15/2024	Nuveen Asset Management LLC	184,146	$6.72M	0.0%	+23.4%	0.294%
2/15/2024	Prelude Capital Management LLC	13,701	$0.50M	0.0%	N/A	0.022%
2/15/2024	Price T Rowe Associates Inc. MD	2,776,570	$101.35M	0.0%	+78.5%	4.437%
2/15/2024	Profund Advisors LLC	24,439	$0.89M	0.0%	-20.4%	0.039%
2/15/2024	Healthcare of Ontario Pension Plan Trust Fund	55,000	$2.01M	0.0%	N/A	0.088%
2/15/2024	Bridger Management LLC	101,126	$3.69M	1.4%	N/A	0.137%
2/15/2024	Bayesian Capital Management LP	6,398	$0.23M	0.0%	N/A	0.010%
2/15/2024	Birchview Capital LP	10,000	$0.37M	0.3%	N/A	0.016%
2/15/2024	Blackstone Inc.	75,000	$2.74M	0.0%	N/A	0.120%
2/15/2024	Comerica Bank	1,132	$41K	0.0%	-22.1%	0.002%
2/14/2024	Royal Bank of Canada	59,860	$2.19M	0.0%	+28.3%	0.096%
2/14/2024	Point72 Asset Management L.P.	2,162,176	$78.92M	0.2%	+310.7%	3.455%
2/14/2024	Cubist Systematic Strategies LLC	6,941	$0.25M	0.0%	N/A	0.011%
2/14/2024	Nebula Research & Development LLC	8,850	$0.32M	0.1%	N/A	0.014%
2/14/2024	Nomura Holdings Inc.	12,690	$0.46M	0.0%	N/A	0.020%
2/14/2024	Lighthouse Investment Partners LLC	28,010	$1.02M	0.0%	N/A	0.045%
2/14/2024	Verition Fund Management LLC	7,804	$0.29M	0.0%	N/A	0.012%
2/14/2024	Sei Investments Co.	27,104	$0.99M	0.0%	+13.3%	0.043%
2/14/2024	Ghisallo Capital Management LLC	50,000	$1.83M	0.2%	N/A	0.080%
2/14/2024	Seven Eight Capital LP	42,303	$1.54M	0.2%	N/A	0.068%
2/14/2024	RTW Investments LP	625,000	$22.81M	0.4%	N/A	0.999%
2/13/2024	Envestnet Asset Management Inc.	66,127	$2.41M	0.0%	+7.8%	0.106%
2/13/2024	Northern Trust Corp	591,382	$21.59M	0.0%	+13.5%	0.945%
2/13/2024	American International Group Inc.	33,357	$1.22M	0.0%	+14.7%	0.053%
2/13/2024	Public Employees Retirement Association of Colorado	4,575	$0.17M	0.0%	-97.8%	0.007%
2/13/2024	Tower Research Capital LLC TRC	4,671	$0.17M	0.0%	+288.9%	0.007%
2/13/2024	Affinity Asset Advisors LLC	100,000	$3.65M	0.7%	+140.5%	0.160%
2/13/2024	First Trust Advisors LP	10,129	$0.37M	0.0%	N/A	0.016%
2/13/2024	Goldman Sachs Group Inc.	461,275	$16.84M	0.0%	-22.1%	0.737%
2/13/2024	Rafferty Asset Management LLC	144,347	$5.27M	0.0%	-19.6%	0.231%
2/13/2024	The Manufacturers Life Insurance Company	109,384	$3.99M	0.0%	+28.0%	0.175%
2/13/2024	Campbell & CO Investment Adviser LLC	13,322	$0.49M	0.0%	N/A	0.021%
2/13/2024	California State Teachers Retirement System	52,787	$1.93M	0.0%	+22.1%	0.084%
2/12/2024	Monashee Investment Management LLC	73,949	$2.70M	0.5%	N/A	0.118%
2/12/2024	M28 Capital Management LP	142,800	$5.21M	4.3%	-27.8%	0.228%
2/12/2024	Stifel Financial Corp	18,206	$0.67M	0.0%	-14.8%	0.029%
2/12/2024	TD Asset Management Inc	181,432	$6.62M	0.0%	+30.7%	0.290%
2/9/2024	Orion Portfolio Solutions LLC	21,754	$0.79M	0.0%	-23.9%	0.035%
2/9/2024	Assetmark Inc.	16,090	$0.59M	0.0%	+48.8%	0.026%
2/9/2024	UBS Group AG	139,672	$5.10M	0.0%	+354.9%	0.223%
2/9/2024	Norges Bank	337,833	$12.33M	0.0%	N/A	0.540%
2/8/2024	Fiera Capital Corp	893,456	$32.61M	0.1%	+0.1%	1.428%
2/8/2024	Massachusetts Financial Services Co. MA	468,078	$17.09M	0.0%	+14.9%	0.748%
2/7/2024	Principal Financial Group Inc.	16,120	$0.59M	0.0%	+8.3%	0.026%
2/7/2024	Dimensional Fund Advisors LP	968,405	$35.35M	0.0%	-4.2%	1.547%
2/7/2024	Teacher Retirement System of Texas	10,268	$0.38M	0.0%	+5.1%	0.016%
2/7/2024	E Fund Management Co. Ltd.	7,752	$0.28M	0.0%	-16.0%	0.012%
2/6/2024	Charles Schwab Investment Management Inc.	501,067	$18.29M	0.0%	+18.2%	0.801%
2/6/2024	Amalgamated Bank	9,666	$0.35M	0.0%	+9.1%	0.015%
2/6/2024	Swiss National Bank	92,400	$3.37M	0.0%	+22.2%	0.148%
2/5/2024	Victory Capital Management Inc.	369,367	$13.48M	0.0%	+795.7%	0.590%
2/5/2024	Russell Investments Group Ltd.	114,154	$4.17M	0.0%	+4.0%	0.182%
2/2/2024	Headlands Technologies LLC	2,023	$74K	0.0%	N/A	0.003%
2/1/2024	New York State Common Retirement Fund	253,741	$9.26M	0.0%	+1.6%	0.405%
2/1/2024	Duality Advisers LP	10,362	$0.38M	0.0%	N/A	0.017%
2/1/2024	Handelsbanken Fonder AB	11,800	$0.43M	0.0%	N/A	0.019%
2/1/2024	CWM LLC	714	$26K	0.0%	-31.5%	0.001%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	8,645	$0.32M	0.0%	+38.1%	0.014%
1/30/2024	Strs Ohio	2,800	$0.10M	0.0%	N/A	0.004%
1/26/2024	Mutual of America Capital Management LLC	64,214	$2.34M	0.0%	N/A	0.103%
1/26/2024	Peregrine Capital Management LLC	136,009	$4.96M	0.1%	-14.7%	0.217%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	36,820	$1.34M	0.0%	+9.5%	0.059%
1/24/2024	DekaBank Deutsche Girozentrale	40,000	$1.49M	0.0%	+131.9%	0.064%
1/24/2024	Arizona State Retirement System	13,088	$0.48M	0.0%	+33.7%	0.021%
1/24/2024	China Universal Asset Management Co. Ltd.	7,237	$0.26M	0.1%	+348.9%	0.012%
1/12/2024	SG Americas Securities LLC	4,315	$0.16M	0.0%	N/A	0.007%
1/5/2024	Exchange Traded Concepts LLC	5,323	$0.19M	0.0%	+34.0%	0.009%
12/18/2023	Vanguard Group Inc.	4,922,462	$113.81M	0.0%	+0.4%	7.866%
12/6/2023	Citigroup Inc.	79,462	$1.84M	0.0%	-9.6%	0.127%
11/24/2023	Deutsche Bank AG	30,671	$0.71M	0.0%	-59.5%	0.049%
11/21/2023	Walleye Capital LLC	144,307	$3.34M	0.0%	+196.8%	0.231%
11/21/2023	Comerica Bank	1,454	$34K	0.0%	-68.1%	0.002%
11/15/2023	The Manufacturers Life Insurance Company	85,442	$1.98M	0.0%	+13.8%	0.137%
11/15/2023	Royal Bank of Canada	46,646	$1.08M	0.0%	+11.1%	0.075%
11/15/2023	Sei Investments Co.	23,926	$0.55M	0.0%	+68.5%	0.038%
11/15/2023	JPMorgan Chase & Co.	566,924	$13.11M	0.0%	-5.2%	0.906%
11/15/2023	Laurion Capital Management LP	371,595	$8.59M	0.1%	-2.0%	0.594%
11/15/2023	Ameriprise Financial Inc.	224,725	$5.20M	0.0%	+0.7%	0.359%
11/15/2023	Affinity Asset Advisors LLC	41,581	$0.96M	0.3%	-68.0%	0.066%
11/14/2023	California State Teachers Retirement System	43,250	$1M	0.0%	-12.9%	0.069%
11/14/2023	Tower Research Capital LLC TRC	1,201	$28K	0.0%	-61.5%	0.002%

Data available starting January 2016

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer. The company is also involved in the development of mirdametinib, an oral small molecule MEK inhibitor that is in Phase 2b clinical trials for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN); mirdametinib + lifirafenib, a combination therapy that is in Phase 1b clinical trial in patients with advanced or refractory solid tumors; and mirdametinib in monotherapy and combination approaches to treat other genetically defined solid tumors, including Phase 1/2 clinical trial for the treatment of pediatric and young adult patients with low-grade gliomas. In addition, it develops Brimarafenib (BGB-3245), an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has collaborations with BeiGene, Ltd. and GlaxoSmithKline LLC; and license agreements with Pfizer Inc. for nirogacestat and mirdametinib. It also has a license agreement with Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain; and Dana-Farber Cancer Institute for a portfolio of novel small molecule inhibitors of Epidermal Growth Factor Receptor. The company was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $40.10

$38.90

$43.80

50 Day Range

MA: $48.10

$42.47

$52.50

52 Week Range

Now: $40.10

$18.00

$53.92

Volume

1,413,521 shs

Average Volume

1,112,465 shs

Market Capitalization

$2.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of SpringWorks Therapeutics?: SpringWorks Therapeutics' top insider investors include:
Orbimed Advisors Llc (Major Shareholder)
Daniel Pichl (Insider)
Julie Hambleton (Director)
Learn More about top insider investors at SpringWorks Therapeutics.
Who are the major institutional investors of SpringWorks Therapeutics?: SpringWorks Therapeutics' top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.05%
Los Angeles Capital Management LLC — 0.02%
Financial Security Advisor Inc. — 0.01%
Learn More about top institutional investors of SpringWorks Therapeutics stock.
Which major investors are buying SpringWorks Therapeutics stock?: In the last quarter, SWTX stock was bought by institutional investors including:
Los Angeles Capital Management LLC
Financial Security Advisor Inc.
Hennion & Walsh Asset Management Inc.